Bibliothek

feed icon rss

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
  • 1
    ISSN: 1534-4681
    Schlagwort(e): Melanoma ; Recurrence ; Disease-free interval ; Lymph node dissection
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Abstract Background: Although more than 90% of the morbidity and mortality from localized cutaneous melanoma occurs in the first decade after initial surgical treatment, melanoma can recur after a 10-year disease-free interval (DFI) with fatal consequences. We reviewed our melanoma data base of more than 8500 prospectively acquired patients to identify clinicopathological factors that affect the type, rate of occurrence, and outcome of disease recurring 10 years or more after surgical treatment of primary cutaneous melanoma. Methods: From 1971 to 1997, 1907 melanoma patients treated at our cancer center reached or presented with a DFI of 10 years or more after surgical treatment of clinically localized melanoma. Of these, 217 (11%) patients had recurrences (mean DFI, 182 months). The sites of recurrence were local/in-transit in 26 (12%) patients, regional lymph nodes in 101 (47%) patients, and distant sites in 90 (41%) patients. Results: Univariate and multivariate analysis, using patient age and sex, type of initial treatment, and the site, Breslow thickness, and Clark level of the initial tumor, showed that the type of treatment for the primary tumor was a significant (P = .0005) prognostic factor in the development of late nodal recurrence. Of the 217 patients who had recurrences, 172 (79%) had undergone wide local excision for their primary melanoma, and 45 (21%) had undergone wide local excision plus elective lymph node dissection (ELND). The rates of nodal recurrence were 53% (92 of 172) and 20% (9 of 45), respectively, a significant (P = .0001) difference. When all patients with a DFI of 10 years or more were stratified by type of initial treatment, the ELND group demonstrated a significant improvement in disease-free survival and overall survival. Conclusions: The risk of late-recurring nodal disease increases and the chance of long-term survival decreases when wide local excision is performed without ELND. With the advent of sentinel lymphadenectomy, ELND can be selectively performed only for those nodal basins with occult tumor cells, thereby decreasing operative morbidity but allowing identification and early removal of nodal micrometastases.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    ISSN: 1432-1440
    Schlagwort(e): Macrophage-electrophoretic-mobility-test ; lymphocyte sensitization ; cell-mediated hypersensitivity ; multiple sclerosis ; malignant neoplasm of central nervous system ; Makrophagen-Elektrophorese-Mobilitäts-Test ; Lymphocytensensibilisierung ; celluläre Immunität ; Multiple Sklerose ; maligne Neoplasmen des Zentralnervensystems
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Beschreibung / Inhaltsverzeichnis: Zusammenfassung Mit dem Makrophagen-Elektrophorese-Mobilitäts-(MEM)-Test (Field u. Caspary) können spezifisch sensibilisierte Lymphocyten — vor allem bei einer cytergischen Immunreaktion — nachgewiesen werden: der bei einer Reihe von Erkrankungen nach Stimulierung der sensibilisierten Lymphocyten mit basischem (encephalitogenem) Myelinprotein oder ähnlichen Antigenen abgegebene macrophage-slowing-factor hemmt die im Cytopherometer ermittelte Wanderungsgeschwindigkeit der Makrophagen. Zur weiteren Feststellung der Wertigkeit des Verfahrens wurden Lymphocyten von 25 Patienten mit verschiedenartigen neurologischen Erkrankungen untersucht. Die Ergebnisse zeigten, daß bei allen Stadien und Verlaufsformen der Multiplen Sklerose eine deutliche Hemmung im MEM-Test auftritt. Neben den Erkrankungen auf der Grundlage einer cellulären Immunität ergaben sich auch mit den Blut-Lymphocyten bei bösartigen Neoplasmen positive Ergebnisse (〉10% Hemmung). Die Befunde bei malignen Tumoren des Zentralnervensystems unterschiedlicher Art und Lokalisation erbrachten — wie die vergleichsweise untersuchten 39 gynäkologischen Carcinome — eine ebenfalls signifikante Reduktion der Makrophagen-Mobilität. Es wurde der diagnostische Wert des Verfahrens besonders fürneuroimmunologische Erkrankungen und Hirntumoren auch bezüglich der weiteren Differenzierungsmöglichkeiten erörtert.
    Notizen: Summary With the macrophage-electrophoretic-mobility (MEM)-test (Field and Caspary) specific sensitized lymphocytes can be detected under the condition of a cell-mediated hypersensitivity. The macrophage-slowing-factor—produced by the patients lymphocytes after stimulation with myelin basic protein or similar antigens—inhibits the electrophoretic mobility of macrophages ascertained by the cytopherometer. To point out the value of the method, the lymphocytes of 25 patients with various neurologic diseases were examined. The results showed that during all stages and forms of multiple sclerosis there appeared a distinct inhibition in the MEM-test. Besides the diseases on the base of a delayed hypersonsitivity there were also positive results (〉10% inhibition) with the blood-lymphocytes from patients with malignant neoplasm. The detection of malignant tumours in the central nervous system of different kind and localization—like the 39 gynaecological carcinoma comparatively studied—also showed a significant reduction of the macrophage mobility. The diagnostic value of the method is discussed especially with reference to neuroimmunologic diseases and brain-tumours and also to the further possibilities of differentiation.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...